The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovary
- 31 October 1986
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 25 (2), 150-159
- https://doi.org/10.1016/0090-8258(86)90096-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Serum lactic dehydrogenase: A tumor marker of ovarian dysgerminoma in a female pseudohermaphroditeGynecologic Oncology, 1984
- Serum Lactic Dehydrogenase—A Possible Tumor Marker for an Ovarian DysgerminomaObstetrical & Gynecological Survey, 1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerThe New England Journal of Medicine, 1983
- Immunopathologic Characterization of a Monoclonal Antibody that Recognizes Common Surface Antigens of Human Ovarian Tumors of Serous, Endometrioid, and Clear Cell TypesAmerican Journal of Clinical Pathology, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.JCI Insight, 1981
- Alpha fetoprotein determinations in the management of endodermal sinus tumors and mixed germ cell tumors of the ovaryAmerican Journal of Obstetrics and Gynecology, 1981
- Chemotherapy of advanced malignant teratomasBritish Journal of Cancer, 1980
- The Role of the Radioimmunoassay of Serum Alpha-Fetoprotein and Human Chorionic Gonadotropin in the Intensive Chemotherapy and Surgery of Metastatic Testicular TumorsJournal of Urology, 1978
- Serum alphafetoprotein (AFP) in diagnosis and management of endodermal sinus (yolk sac) tumor and mixed germ cell tumor of the ovaryCancer, 1978
- Relative frequency of ovarian neoplasms in children and adolescentsCancer, 1972